Filing Details
- Accession Number:
- 0000950103-22-000900
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-20 19:55:17
- Reporting Period:
- 2022-01-18
- Accepted Time:
- 2022-01-20 19:55:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543795 | Robert Spurr | C/O Bausch Health Companies Inc. 400 Somerset Corporate Blvd. Bridgewater NJ 08807 | U.s. President-Pharma Business | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Disposition | 2022-01-18 | 3,251 | $26.63 | 63,550 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.
Billionaire Hedge Funds
